Vaidehi Thanawala

Vaidehi Thanawala

VIR Biotechnology - / United States
Others
AD Scientific Index ID: 4524266
Vir Biotechnology
person_outline Vaidehi Thanawala's MOST POPULAR ARTICLES
1-) Enkephalinase inhibitors: potential agents for the management of painV Thanawala, VJ Kadam, R GhoshCurrent drug targets 9 (10), 887-894, 2008842008
2-) β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine modelVJ Thanawala, GS Forkuo, N Al-Sawalha, Z Azzegagh, LP Nguyen, ...American journal of respiratory cell and molecular biology 48 (2), 220-229, 2013602013
3-) Ligand bias prevents class equality among beta-blockersVJ Thanawala, GS Forkuo, W Stallaert, P Leff, M Bouvier, R BondCurrent opinion in pharmacology 16, 50-57, 2014302014
4-) β‐Blockers have differential effects on the murine asthma phenotypeVJ Thanawala, DJ Valdez, R Joshi, GS Forkuo, S Parra, BJ Knoll, ...British journal of pharmacology 172 (20), 4833-4846, 2015272015
5-) Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase–Knockout MiceGS Forkuo, H Kim, VJ Thanawala, N Al-Sawalha, D Valdez, R Joshi, ...American journal of respiratory cell and molecular biology 55 (2), 234-242, 2016262016